Gene · 3635
Papers3,499
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,499
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Universal method for the isolation of microvessels from frozen brain tissue: A proof-of-concept multiomic investigation of the neurovasculature. | Brain Behav Immun Health | 2023 | 37822873 | PubTator, text mining | PubMed |
| Identification of molecular pattern and prognostic risk model based on ligand-receptor pairs in liver cancer. | Front Immunol | 2023 | 37818360 | PubTator, text mining | PubMed |
| European and multi-ancestry genome-wide association meta-analysis of atopic dermatitis highlights importance of systemic immune regulation. | Nat Commun | 2023 | 37794016 | PubTator, text mining | PubMed |
| Functionally Relevant Cytokine/Receptor Axes in Myelofibrosis. | Biomedicines | 2023 | 37760903 | PubTator, text mining | PubMed |
| Regulation of Phosphoinositide Signaling by Scaffolds at Cytoplasmic Membranes. | Biomolecules | 2023 | 37759697 | PubTator, text mining | PubMed |
| miR155, TREM2, INPP5D: Disease stage and cell type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer's amyloidopathy. | J Neuroinflammation | 2023 | 37749581 | PubTator, text mining | PubMed |
| SHIP1 and its role for innate immune regulation-Novel targets for immunotherapy. | Eur J Immunol | 2023 | 37742135 | PubTator, text mining | PubMed |
| In-silico identification and prioritization of therapeutic targets of asthma. | Sci Rep | 2023 | 37735578 | PubTator, text mining | PubMed |
| KL is a favorable prognostic factor related immune for clear cell renal cell carcinoma. | Eur J Med Res | 2023 | 37726833 | PubTator, text mining | PubMed |
| The macrophage polarization by miRNAs and its potential role in the treatment of tumor and inflammation (Review). | Oncol Rep | 2023 | 37711048 | PubTator, text mining | PubMed |
| Inhibition of pro-inflammatory signaling in human primary macrophages by enhancing arginase-2 via target site blockers. | Mol Ther Nucleic Acids | 2023 | 37701067 | PubTator, text mining | PubMed |
| APOE-ε4 and BIN1 increase risk of Alzheimer's disease pathology but not specifically of Lewy body pathology. | Acta Neuropathol Commun | 2023 | 37700353 | PubTator, text mining | PubMed |
| iHerd: an integrative hierarchical graph representation learning framework to quantify network changes and prioritize risk genes in disease. | PLoS Comput Biol | 2023 | 37695793 | PubTator, text mining | PubMed |
| The role of macrophages polarization in sepsis-induced acute lung injury. | Front Immunol | 2023 | 37691951 | PubTator, text mining | PubMed |
| Cancer immunotherapies: advances and bottlenecks. | Front Immunol | 2023 | 37691932 | PubTator, text mining | PubMed |
| Inhibitory Fc-Gamma IIb Receptor Signaling Induced by Multivalent IgG-Fc Is Dependent on Sialylation. | Cells | 2023 | 37681862 | PubTator, text mining | PubMed |
| Development of a prognostic model for anoikis and identifies hub genes in hepatocellular carcinoma. | Sci Rep | 2023 | 37679418 | PubTator, text mining | PubMed |
| Time-dependent cell-state selection identifies transiently expressed genes regulating ILC2 activation. | Commun Biol | 2023 | 37673922 | PubTator, text mining | PubMed |
| Multiplex interrogation of the NK cell signalome reveals global downregulation of CD16 signaling during lentivirus infection through an IL-18/ADAM17-dependent mechanism. | PLoS Pathog | 2023 | 37669308 | PubTator, text mining | PubMed |
| Insulin signaling and its application. | Front Endocrinol (Lausanne) | 2023 | 37664840 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3635/papers?page=11